Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IMCR
IMCR logo

IMCR

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMCR News

Immunocore (IMCR) Q4 2025 Earnings Call Transcript

Feb 25 2026NASDAQ.COM

Immunocore Q4 Earnings Report Analysis

Feb 25 2026seekingalpha

Immunocore Set to Announce Q4 Earnings on February 25

Feb 24 2026seekingalpha

Immunocore Announces R&D Leadership Changes

Jan 30 2026Newsfilter

Immunocore to Showcase at Upcoming Investor Events

Nov 10 2025Newsfilter

HC Wainwright & Co. Affirms Buy Rating for Immunocore Holdings, Keeps $100 Price Target Intact

Oct 22 2025Benzinga

H.C. Wainwright Maintains Positive Outlook on Immunocore Holdings plc (IMCR)

Oct 21 2025Yahoo Finance

Resolution Therapeutics names Lucy Singah as CFO and Daniel Kennedy as CBO

Sep 10 2025Newsfilter

Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript

Aug 09 2025Newsfilter

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

Aug 08 2025NASDAQ.COM

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Aug 06 2025NASDAQ.COM

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

Aug 06 2025NASDAQ.COM

BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark

Aug 06 2025NASDAQ.COM

Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions

Jun 30 2025Globenewswire

FDA Extends INCY's Application for Opzelura Label Expansion

Jun 23 2025NASDAQ.COM

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Jun 20 2025NASDAQ.COM